Associated Papers
Relevance of mutations in protein deubiquitinases genes and TP53 in corticotroph pituitary tumors.
Pękul M et al.
Frontiers in Endocrinology, 2024
Hotspots of Somatic Genetic Variation in Pituitary Neuroendocrine Tumors.
Torres-Morán M et al.
Cancers, 2023
[Molecular genetic abnormalities in ACTH-secreting pituitary tumors (corticotropinomas): fundamental research and prospects for use in clinical practice].
Lapshina AM
Problemy Endokrinologii, 2023
Pituitary Tumorigenesis-Implications for Management.
Vamvoukaki R et al.
Medicina (kaunas, Lithuania), 2023
The Expression of Cell Cycle-Related Genes in USP8-Mutated Corticotroph Neuroendocrine Pituitary Tumors and Their Possible Role in Cell Cycle-Targeting Treatment.
Mossakowska BJ et al.
Cancers, 2022
Genetic Basis of ACTH-Secreting Adenomas.
Locantore P et al.
International Journal of Molecular Sciences, 2022
USP8, USP48, and BRAF mutations differ in their genotype-phenotype correlation in Asian Indian patients with Cushing's disease.
Abraham AP et al.
Endocrine, 2022
The genomic profiling and MAMLD1 expression in human and canines with Cushing's disease.
Wang A et al.
Bmc Endocrine Disorders, 2021
Genetic Profiling of a Cohort of Italian Patients with ACTH-Secreting Pituitary Tumors and Characterization of a Novel USP8 Gene Variant.
Treppiedi D et al.
Cancers, 2021
Differential microRNA Expression in USP8-Mutated and Wild-Type Corticotroph Pituitary Tumors Reflect the Difference in Protein Ubiquitination Processes.
Bujko M et al.
Journal of Clinical Medicine, 2021
Genetic and Epigenetic Causes of Pituitary Adenomas.
Chang M et al.
Frontiers in Endocrinology, 2020
Driver mutations in USP8 wild-type Cushing's disease.
Sbiera S et al.
Neuro-oncology, 2019
Identification of recurrent USP48 and BRAF mutations in Cushing's disease.
Chen J et al.
Nature Communications, 2018
Select a paper to view details